May 9, 2023
LOS ANGELES–(BUSINESS WIRE)–Non-invasive cardiac assessment company Sensydia today announced it has raised approximately $8M in new funding from an expanded syndicate of investors. Proceeds of the financing will enable the company to prepare for commercialization of its groundbreaking non-invasive cardiac assessment platform, Cardiac Performance System (CPS™). Sensydia continues to push the boundaries of its heart-sound AI technology, which promises to transform the diagnosis and management o
Go to Source
Author: